Physician profile
Ashley Loe
NPI 1568948875
$3,376.82
in general payments reported to CMS, 2019-2025
30 companies · $578 in 2025
The $578 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $969 · 2022: $830 · 2023: $607 · 2024: $393 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $453.19 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $412.13 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $360.68 | 2021-2024 | Verquvo, Belsomra |
| Astrazeneca Pharmaceuticals Lp | $340.07 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $217.86 | 2021-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $211.55 | 2025 | Rexulti |
| Pfizer INC. | $183.44 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.46 | 2021-2023 | Jardiance |
| Irhythm Technologies, INC. | $122.93 | 2022-2024 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $103.97 | 2021-2023 | |
| Medtronic, INC. | $85.06 | 2023-2025 | Linq II, Micra |
| Baxter Healthcare | $76.62 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Abbvie INC. | $70.40 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.80 | 2021 | |
| Boston Scientific Corporation | $57.13 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $53.56 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $49.25 | 2022-2023 | |
| Novo Nordisk INC | $48.69 | 2023-2024 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $44.27 | 2021-2023 | Nexletol |
| Edwards Lifesciences Corporation | $43.53 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Philips North America LLC | $42.88 | 2022-2025 | Extended Holter |
| Kiniksa Pharmaceuticals International, Plc | $38.10 | 2024 | Arcalyst |
| Innovation Technologies INC | $25.85 | 2025 | Irrisept |
| Actelion Pharmaceuticals US, INC. | $21.43 | 2025 | Uptravi, Opsumit |
| Cvrx, INC. | $21.30 | 2024 | Barostim Neo System |
| Genzyme Corporation | $21.15 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.82 | 2025 | |
| Alnylam Pharmaceuticals INC. | $17.49 | 2022 | |
| Amarin Pharma, INC. | $17.17 | 2021 | |
| Exact Sciences Corporation | $14.04 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Loe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.